GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 63 filers reported holding GAMIDA CELL LTD in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $30,079 | -46.6% | 29,203 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $56,362 | +138.3% | 29,203 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $23,654 | -37.2% | 29,203 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $37,672 | -24.7% | 29,203 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $50,000 | -3.8% | 29,203 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $52,000 | -57.0% | 29,203 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $121,000 | +63.5% | 29,203 | 0.0% | 0.00% | +100.0% |
Q4 2021 | $74,000 | -35.1% | 29,203 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $114,000 | -51.7% | 29,203 | 0.0% | 0.00% | -60.0% |
Q1 2021 | $236,000 | -36.2% | 29,203 | -33.9% | 0.01% | -50.0% |
Q4 2020 | $370,000 | +58.8% | 44,203 | -25.3% | 0.01% | 0.0% |
Q3 2020 | $233,000 | -8.3% | 59,203 | 0.0% | 0.01% | -9.1% |
Q2 2020 | $254,000 | +195.3% | 59,203 | +102.7% | 0.01% | +175.0% |
Q1 2020 | $86,000 | -31.2% | 29,203 | 0.0% | 0.00% | -20.0% |
Q4 2019 | $125,000 | +3.3% | 29,203 | 0.0% | 0.01% | -16.7% |
Q3 2019 | $121,000 | – | 29,203 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 3,318,207 | $26,844,000 | 2.86% |
Stonepine Capital Management, LLC | 244,515 | $1,978,000 | 1.07% |
Healthcare Value Capital, LLC | 50,000 | $405,000 | 0.90% |
Rock Springs Capital Management LP | 2,100,300 | $16,991,000 | 0.37% |
Dorsey Wright & Associates | 3,619 | $29,278,000 | 0.34% |
FIRST MIDWEST BANK TRUST DIVISION | 302,487 | $2,447,000 | 0.34% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $862,000 | 0.23% |
Guild Investment Management, Inc. | 15,000 | $121,000 | 0.13% |
PREMIER ASSET MANAGEMENT LLC | 86,464 | $699,000 | 0.12% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 973,575 | $7,876,000 | 0.12% |